Scholar Rock Holding Corp (SRRK) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $44.84
• Market Cap: $4.79B
• EPS: $-3.15
• 52-Week High: $49.82
• 52-Week Low: $22.71

Market Sentiment

Scholar Rock Holding Corp currently has a Neutral sentiment score of 0.15.

About Scholar Rock Holding Corp

Scholar Rock Holding Corporation is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, specializing in the development of targeted therapies for serious diseases influenced by protein growth factor signaling. Utilizing a pioneering approach to harness the therapeutic potential of the TGF-beta superfamily, Scholar Rock is advancing a promising pipeline that addresses critical conditions, including muscular dystrophy and various cancers. Committed to transform...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Scholar Rock Holding Corp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SRRK pay dividends?

Scholar Rock Holding Corp (SRRK) does not currently pay a regular dividend.

What is SRRK's market cap?

Scholar Rock Holding Corp (SRRK) has a market capitalization of $4.79B with a current stock price of $44.84.